Previous 10 | Next 10 |
Patient investors can often ignore the market's short-term volatility while waiting to see how their investment thesis unfolds. Sometimes, the party has already started, and companies are beginning to see their long-term plans come to fruition. In fact, that might be an ideal time to initia...
This a great market for stock pickers. Multiples have been cut in half for a lot of small-caps as the stock market has no appetite for risk right now. Nonetheless, if you do a lot of digging, you can find stocks with remarkable upside. Here's why our roundtable likes Affimed (NASD...
Findings Show Tablo® Hemodialysis System Increases Patient and Physician Likelihood to Adopt Home Hemodialysis (HHD) Today, Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis, announc...
Update 11:52am: Adds confirmation of statement from PCAOB, talking points at bottom. Alibaba (NYSE:BABA) and several other Chinese tech stocks dropped after a report that the U.S. audit watchdog said speculation on a deal that would prevent hundreds of Chinese companies from being removed fro...
It's been an ugly year in the stock market so far, and both good and bad stocks have been hammered. Now's a great time to go shopping if you have the cash. Our roundtable has three biotech stocks that could be worth significantly more over the next three years than they are right now. H...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42 nd Annual Cowen ...
After a terrible January, investors had hoped that stock markets would be able to recover in February. Yet volatility has continued to rule the day, and persistent fears about interest rates and inflation have been particularly hard on the Nasdaq Composite (NASDAQINDEX: ^IXIC) . As ...
Outset Medical's (OM +16.6%) Q4 2021 revenue beat and bullish guidance for 2022 led Morgan Stanley to upgrade the stock to overweight from equal-weight. However, the firm lowered its price target to $50 from $55 (~46% upside based on Wednesday's close). Analyst Drew Ranieri said that the resu...
Outset Medical (OM +14.1%) rose Feb. 17, after Q4 revenues grew ~63.2% Y/Y to $28.15M. The company also said that Leslie Trigg was appointed Chair of the board in addition to her ongoing role as president and CEO. Former Chairman D. Keith Grossman will continue to serve on the board...
Outset Medical (OM +14.1%) has recorded the biggest intraday gain since Nov. 2020 on Thursday after projecting better-than-anticipated revenue guidance for 2022 despite a mixed performance on its Q4 2021 financials. The quarterly revenue jumped ~63% YoY to $28.2M expanding the annual revenue ...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...